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Effect of intravitreal octreotide acetate injection on retinal
neovascularization, morphology, and apoptotic cell death in an
oxygen-induced retinopathy mouse model
Fatma Selin KAYA1, İmren AKKOYUN1, Asuman Nihan HABERAL REYHAN2, Attila DAĞDEVİREN3,
Gürsel YILMAZ1, Sibel OTO1, Yonca AKOVA1

Aim: To investigate the effect of octreotide acetate on neovascularization, retinal structures, and apoptotic cell death in
an oxygen-induced retinopathy (OIR) mouse model.
Materials and methods: A total of 26 C57BL/6J mice were exposed to 75 ± 2% oxygen from postnatal day 7 to 12. On
day 12, 12 mice (group C) were injected with 0.1 µg intravitreal octreotide acetate (IVOA) and 14 mice (group D) were
injected with 0.05 µg IVOA, in the right eye. The contralateral eyes were injected with 1 µL isotonic saline (control
group, group B). Four mice were used as negative controls (group A). Neovascularization was quantified by counting
the number of retinal vascular endothelial cell nuclei anterior to the inner limiting membrane. Structural changes were
examined by light and electron microscopy. Apoptosis was investigated using the TUNEL technique.
Results: The retinal vascular endothelial cell nuclei count was lower in groups C (P < 0.0001) and D (P < 0.0001)
compared with group B. Light microscopy showed no retinal toxicity. Electron microscopy showed mitochondrial
damage in the inner segment of the photoreceptors in the OIR mouse model without increasing in the IVOA-injected
groups. There was no significant difference in the apoptotic cell death in any of the groups.
Conclusion: There was mitochondrial damage in the inner segment of the photoreceptors in the OIR mouse model
without increasing the apoptotic cell death.
Key words: Oxygen-induced retinopathy mouse model, neovascular ocular diseases, apoptosis, mitochondria,
octreotide acetate

Introduction
Pathologic retinal angiogenesis is a final common
pathway leading to vision loss in neovascular ocular
diseases such as retinopathy of prematurity, diabetic
retinopathy, and age-related macular degeneration
(1–3). Vascularization requires a complex series of
cellular events that are initiated and modulated by
various growth factors (4,5). Vascular endothelial
growth factor (VEGF) has been localized to both
retinal cells and microvascular endothelium (2,6).

Although the vascular bed and distribution of
tissue disease varies across these ocular neovascular
diseases, the proliferation of aberrant blood vessels
is common to all (2,3,7,8). Drugs that inhibit the
biological activity of VEGF or the insulin-like growth
factor-1 (IGF-1) axis represent a new paradigm in
the treatment of intraocular neovascular diseases.
The currently used anti-VEGF drugs are pegaptanib,
ranibizumab, and bevacizumab. Somatostatin, also
known as the growth hormone-inhibiting hormone,
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has an antiangiogenic effect (4,5,9). Inhibition
of angiogenesis in proliferative retinopathies
using somatostatin analogs has been investigated
(10,13). Systemic therapy with somatostatin analog
octreotide was described to result in the regression
of neovascularization (14). Somatostatin and its
receptors are promising candidates for such an action
(15). Systemic therapy with somatostatin analog
octreotide was described recently in the clinical
trials of diabetic retinopathy treatments, but with
conflicting results (11,13,15,16).
In the present study, we investigated the
effects of intravitreal octreotide acetate (IVOA)
injection on retinal neovascularization at 2
different concentrations, evaluated the drug-related
morphological and ultrastructural changes using light
microscopy (LM) and electron microscopy (EM), and
determined apoptotic cell death in a well-established
oxygen-induced retinopathy (OIR) mouse model
using C57BL/6J mice (7). The OIR in the mouse, with
vascular development similar to that in human and
reproducible and quantifiable proliferative retinal
neovascularization, is useful for the study of the
pathogenesis of retinal neovascularization, as well
as for the study of medical intervention for retinal
vasculopathies (6).
Materials and methods
All of the animals were treated in accordance
with the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals
in Ophthalmic and Vision Research. The animal
procedures were approved by the local Animal Care
and Use Committee of Başkent University.
Experimental protocol
We used a murine model of OIR that was described
previously and in which retinal neovascularization is
induced reproducibly (7). Briefly, on postnatal day
(P) 7, C57BL/6J mice were placed in a hyperoxic
chamber (75 ± 2% oxygen) for 5 days with their
nursing mothers. On P12, the mice were removed
from the chamber and placed in room air (21%
oxygen). A commercially available solution of
octreotide acetate (Novartis, USA) was used. The
octreotide acetate was obtained directly from a vial
of octreotide acetate, undiluted from its solvent
vehicle. During the experiment, we used the doses
1520

of 0.1 µg and 0.05 µg. For the 0.1 µg octreotide
acetate injection, 1 µL of the original suspension was
injected. For the 0.05 µg octreotide acetate injection,
1.0 mL of the original solution was diluted with
1.0 mL sterile saline, whereupon 1 µL of the new
solution was immediately injected into the vitreous
cavity. The mice were deeply anesthetized using an
intraperitoneal injection of ketamine hydrochloride
(40 mg/kg) and xylazine hydrochloride (5 mg/mL).
Additionally, the eye was desensitized with a drop
of 0.5% proparacaine hydrochloride. Intravitreal
injections were performed on P12 with a 32-gauge
needle and Hamilton syringe under direct observation
with a stereoscopic microscope, at the corneoscleral
junction, at the 6 o’clock position. The right eye
received an intravitreal injection of 1 µL octreotide
acetate and the left eye received 1 µL of isotonic saline
(NaCl) in the same position. Four mice of the same
age that had been kept in room air, without exposure
to high levels of oxygen, served as the negative
controls. On P17, the mice were killed using an
intraperitoneal injection of ketamine hydrochloride
(100 mg/kg) and xylazine hydrochloride (5 mg/mL),
and the eyes were enucleated.
A total of 26 C57BL/6J mice were exposed to 75 ±
2% oxygen from P7 to P12. On day 12, 12 mice (group
C, n = 12 eyes) were injected with 0.1 µg IVOA and 14
mice (group D, n = 14 eyes) were injected with 0.05
µg IVOA, in the right eye. The contralateral eyes were
injected with isotonic saline (control group, group B,
n = 26 eyes). Four age-matched mice, maintained in
room air, were used as the negative controls (negative
control, group A, n = 8 eyes). The enucleated eyes
were examined by LM (in groups A, B, C, and D, 5,
23, 9, and 11 eyes, respectively) and EM (3 eyes in
each group). The extent of apoptosis was investigated
using the terminal deoxynucleotidyl transferasemediated dUTP nick end labeling (TUNEL)
technique. TUNEL staining was performed using
paraffin sections, which were used for LM (in group
A, 5 eyes; in groups B, C, and D, 6 eyes in each group).
Light microscopy
The enucleated eyes were fixed with 4% formalin
and embedded in paraffin for light microscopic
evaluation. Serial sections of the retina (6 µm thick)
were obtained starting from the optic disk. The second
or third sections after the optic disk were taken for
evaluation. One section per eye was evaluated. For the
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quantitative assessment of retinal neovascularization,
periodic acid–Schiff and hematoxylin-stained
serial sections were used. Neovascularization was
quantified by counting the number of retinal vascular
endothelial cell nuclei anterior to the inner limiting
membrane (ILM) per histological section of the
retina. In the morphological analysis of retinal layers,
findings such as cystic degeneration, hypocellularity,
or loss of the nuclear layer were investigated
specifically for each group. The slides were examined
using LM (OLYMPUS BX51, Germany).
Electron microscopy
For the electron microscopic examination, all of the
tissues were fixed in phosphate buffer containing 2.5%
glutaraldehyde for 2–3 h. Next, they were postfixed
in 1% osmium tetroxide (OsO4) and dehydrated in
a series of graded alcohols. After passing through
propylene oxide, the specimens were embedded in
Araldite CY212, 2-dodecenyl succinic anhydride
(DDSA), benzyl dimethyl amine (BDMA), and
dibutyl phthalate. Semithin sections were cut and
stained with toluidine blue and examined with a light
microscope. Ultrathin sections were stained with
uranyl acetate and lead citrate and examined with
a LEO 906E EM transmission electron microscope.
Evaluation of the ultrastructural morphology,
especially of the inner and outer photoreceptor
layers, was performed in each group using EM.
The EM and LM assessments of the retinal tissues
were performed by 2 independent observers in a
blinded fashion.

Statistical analyses
The results are reported as means ± standard
deviations (SDs). One-way analysis of variance
(Statistica 10.0, StatSoft Inc., Tulsa, Oklahoma, USA)
was performed on all of the documented parameters.
The independent variables were experimental
conditions (groups A, B, C, D). As results, P-values
are reported in the Figures. In cases of an overall
significant difference (P < 0.05), Duncan’s post hoc
test was used to identify differences among any of the
4 groups (groups A–D). P < 0.05 indicated significant
differences. Figures were plotted using IBM SPSS
Statistics Release 19.0.0.1 (IBM Corporation,
Armonk, New York, USA).
Results
Quantification of proliferative retinopathy with and
without IVOA injection
The degree of hyperoxia-induced neovascularization
was quantified in serial paraffin sections by counting
the endothelial cell nuclei on the vitreal side of the
ILM. In group B (control group), the retina contained
multiple neovascular tufts extending into the vitreous
(Figure 1). These tufts originated from the retinal
vessels, forming clusters of immature endothelial
cells. In this group, the mean ± SD of the endothelial
nuclei anterior to the ILM was 19.9 ± 2.6 per

The TUNEL technique
The enucleated globes were fixed in 4%
paraformaldehyde and embedded in paraffin. Serial
sections of the retina (6 µm thick) were obtained,
starting from the optic disk. The third or fourth
sections after the optic disk were taken for evaluation
and stained with hematoxylin and eosin. One
section per eye was evaluated. TUNEL staining was
performed with a kit (In Situ Cell Death Detection
Kit, AP, Roche Diagnostics GmbH, Mannheim,
Germany) according to the manufacturer’s
instructions. Two independent observers were used
in blinded-fashion LM to look for TUNEL-positive
cells in randomly selected fields on each slide and
at 100× magnifications (oil immersion). Apoptotic
TUNEL-positive cells were counted in 10 randomly
selected fields on each slide.

Figure 1. Light micrographs of C57BL/6J mice retina. Group
B = control group; arrow indicates neovascular tuft
extending into the vitreous. Original magnification
20×.
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histological section. The endothelial cell nuclei count
was 5.1 ± 1.0 in group C (0.1 µg IVOA) and 6.9 ± 1.4
in group D (0.05 µg IVOA). Groups C (P < 0.0001)
and D (P = 0.0001) displayed significant differences
compared with group B, the control group. There was
no significant difference between groups C and D (P
= 0.23). Significant differences were obtained when
group A was compared with groups B, C, and D (P <
0.0001) (Figure 2). Compared with the control group
(group B), the endothelial cell nuclei counts were
reduced by 75% in group C (0.1 µg IVOA) and 65%
in group D (0.05 µg IVOA).
Morphological analysis using light microscopy
There were no morphological changes such as cystic
degeneration, hypocellularity, and losses in the
photoreceptor cell layer using LM evaluation in any
of the groups (Figure 3).
Ultrastructural analysis using electron microscopy
The evaluation of the ultrathin sections revealed
no distinguishable sign of morphological
changes in the negative control group (group A),
including mitochondria in the inner segment
of the photoreceptors (Figure 4). In the control
group (group B), there were some changes in the
morphology of mitochondria, seen as a mottled

Endothelial cell nuclei count
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P < 0.0001

20
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Neg. contr. Contr. group 0.1 µg IVOA 0.05 µg IVOA
(Group - A) (Group - B) (Group - C) (Group - D)

Figure 2. Histogram showing the count of neovascular cell nuclei
on the vitreal side of the inner limiting membrane
of the retina in the OIR model with C57BL/6J mice
in different study groups. Mean ± SD values are the
results of analysis of variance (ANOVA) and denote
differences by experiment (groups A–D).
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Apoptosis analysis with the TUNEL technique
For each sample, the number of TUNEL-positive
cells was determined. In the negative control group,
the control group, and the IVOA-injected groups, we
detected apoptotic TUNEL-positive cells in the outer
nuclear layer and the inner nuclear layer, without a
significant difference between the groups (Figures
7 and 8). There was no significant difference when
group A was compared with groups B (P = 0.8), C (P
= 0.7), or D (P = 0.6). No significant difference was
seen when group B was compared with groups C (P =
0.9) or D (P = 0.8). There was no difference between
groups C and D (P = 0.7).
Discussion

12

0

matrix and electron-dense bodies in the central
region of the cristae surrounded by a lytic matrix and
cristalysis in the inner segment of the photoreceptors
(Figure 5). These ultrastructural changes were
also detectable in IVOA-injected groups C and D.
To quantify the mitochondrial dysmorphology in
the groups, we defined an atypical mitochondrion
with a mottled matrix and electron-dense bodies
in the central region of the cristae and extensive
cristalysis, and we counted the numbers of these
in the fields of view using the same magnification
(3250×) for each sample in the given area for each
group. The results are given in Figure 6. Regarding
the atypical mitochondria counts, groups B, C, and
D, when compared with the negative control group,
displayed significant differences (P < 0.0001). There
was no significant difference between groups C and
D when compared with the control group (P = 0.09
and P = 0.16, respectively). There was no significant
difference between groups C and D (P = 0.08).

In the present study, using a well-established OIR
mouse model with C57BL/6J mice, we observed the
effect of intravitreally injected octreotide acetate on
retinal endothelial cell proliferation and the effect
on retinal structures and apoptosis with different
octreotide acetate concentrations.
We demonstrated a dose-independent decrease
in the retinal endothelial cell count with intravitreal
injections of 0.05 µg and 0.1 µg octreotide acetate.
This finding suggests that octreotide acetate may
have an antiangiogenic effect on retinal endothelial
cell proliferation. The octreotide acetate potently
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Figure 3. Light micrographs of C57BL/6J mice retina. The sections were taken from
almost the same region of the retina in all of the groups. A) Mouse retina
exposed to room air (group A, negative control group); B) isotonic salineinjected eye, exposed to hyperoxia from P7 to P12 (group B, control group;
the arrow indicates endothelial cell proliferation; C) eye injected with 0.1 µg
IVOA (group C); D) eye injected with 0.05 µg IVOA (group D). Original
magnification 20×.

inhibited proliferation of bovine retinal endothelial
cells induced with basic fibroblast growth factor
(bFGF), VEGF, and IGF-1 under hypoxic conditions
(18). Woltering et al. used the octreotide dosages of
0.5 µg, 2.5 µg, and 50 µg to inhibit angiogenesis in the
chick disk and they observed inhibition rates of 15%,
56%, and 61%, respectively (19).
Smith et al. reported that in transgenic mice
expressing a growth hormone antagonist gene
and subjected to OIR, retinal neovascularization
was reduced by 34% (20). Some in vivo studies

demonstrated suppression of retinal revascularization
in an OIR model using C57BL/6J mice (17,21). They
reported a neovascularization suppression rate of
26% after an intraperitoneal injection of octreotide
at a dose of 20 mg/kg twice a day (17). In another
study, it was reported that intraperitoneal injections
of octreotide acetate twice a day failed to inhibit
neovascularization in a rat model of retinopathy
of prematurity, although pharmacological serum
octreotide levels were achieved (22). In our study,
after intravitreal injection of octreotide acetate, we

Figure 4. Electron micrograph: a section through the inner
segments of photoreceptor cells (negative control
group, group A). Mitochondrion reflects the usual fine
structural characteristics.

Figure 5. Electron micrograph: group B = control group.
Morphological changes in the mitochondria as mottled
matrix and electron-dense bodies in the central region
of cristae surrounded by lytic matrix and extensive
cristalysis.
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Atypical mitochondria count

20

P = 0.0007

It has been found that octreotide injected
intravitreally in New Zealand white rabbit eyes was
safe at dosages of 1 mg or less (27). In our study,
octreotide acetate did not cause morphological
changes in LM in layers of the retina in eyes with
pigmented tissue in C57BL/6J mice in an OIR model
treated with 0.1 µg and 0.05 µg IVOA.

16

12

8

4

0

Neg. contr. Contr. group 0.1 µg IVOA 0.05 µg IVOA
(Group - A) (Group - B) (Group - C) (Group - D)

Figure 6. Histogram showing the number of atypical
mitochondria in different study groups in the retina
of C57BL/6J mice using an experimental model of
oxygen-induced retinopathy. Mean ± SD values are the
results of analysis of variance (ANOVA) and denote
differences by experiment (groups A–D).

observed a suppression rate of 65% in the 0.05 µg
IVOA group and 75% in the 0.1 µg IVOA group
in an OIR mouse model with C57BL/6J mice. It
was shown in C57BL/6J mice that somatostatin
receptor-2 (SSTR2) is the main mediator of the
ocular antiangiogenic procedures (23). The peptide
octreotide does not cross the blood–brain barrier and
would have access only where there is a disruption
of the blood–retinal barrier, limiting the amount of
drug reaching the retinal target tissue when injected
subcutaneously (23). This could explain the higher
dose requirements of systemic octreotide therapy. In
vitro antiangiogenic activity of somatostatin agonists
indicates a paracrine mechanism of action. Thus, the
therapeutic effects of the octreotide are hypothesized
to be mediated by somatostatin receptor activation
directly on the ocular target tissue (23–25).
McCombe et al. suggested that somatostatin analogs
may act at the retinal level to inhibit the activity of
growth hormone and IGF-1 locally, rather than at
the level of the pituitary (26). These angioinhibitory
effects, initiated by SSTR2 activation, involve the
downregulation of VEGF. The signal transducer and
activator of transcription 3 (stat3) is the downstream
effector mediating this antiangiogenic action
(25). These findings support the assumption that
octreotide may be efficient via local administration
1524

and are consistent with the high neovascularization
suppression rate in the present study.

It is well known that in OIR, hyperoxia deprivation
induces relative hypoxia in the tissue (2), and this
provokes swelling, fragmentation of the cristae,
condensation of the matrix, and fading of the outer
and inner membranes of the mitochondria (28,29).
In accordance with the literature, in our control
group (group B), which represents the OIR group
without octreotide acetate, in the ultrastructural
morphological investigation using EM, there was
a mottled matrix and electron-dense bodies in the
central region of the cristae surrounded by a lytic
matrix and extensive cristalysis, maintaining the
mitochondrial configuration in the outer borders
in the inner segment of the photoreceptors. These
findings, visible in the hyperoxia-exposed control
group, indicate hyperoxia vulnerability of the
C57BL/6J retina.
The internal structures of the mitochondria
can change in response to their physiological state
and reaction to a stress signal, such as exposure to
hyper- or hypoxia (30). The level of stress seems to
determine the morphological and functional changes
in the mitochondria. These changes can induce the
survival of the cell or lead to apoptosis (31). Using
TUNEL staining, we detected apoptosis in the
negative control group and in the control group,
without a significant increase in apoptotic cell death
in the OIR group (control group) as demonstrated
in a previous study (32). Furthermore, we detected
apoptosis in the IVOA-injected groups without a
significant increase in apoptotic cell death compared
with the OIR group and control group. Apoptosis
occurs normally in many physiological processes
and serves to eliminate harmful or unnecessary cells.
Death by apoptosis is also responsible for the loss of
cells in a variety of pathologic states, such as hypoxia
or cytotoxic agents (33). In our study, we detected a
physiological apoptotic process and no toxic effect
of IVOA at concentrations of 0.1 µg and 0.05 µg
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Figure 7. Light micrographs of C57BL/6J mice retina showing assessed apoptotic cells
using TUNEL assay. Each slide represents the 5 independent experiments
in groups A–D. Apoptotic cells are deeply pigmented (arrow) in the outer
nuclear layer and inner nuclear layer in each group. Original magnification
100×, oil immersion.

octreotide in an OIR mouse model as examined by
TUNEL staining.
In conclusion, our study demonstrated that an
intravitreal injection of octreotide acetate suppresses

Apoptotic cell count

6
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3

endothelial cell proliferation in an OIR mouse model
using C57BL/6J mice. LM did not show retinal
toxicity in any of the groups. The electron microscopic
cytoarchitectonic evaluation revealed mitochondrial
damage in the inner segment of the photoreceptors
in OIR without an increase in the IVOA-injected
groups. There was no increasing apoptotic cell death
in the IVOA-injected groups. The study described
herein implies that an intravitreal injection of
octreotide acetate may be a potential treatment for
proliferative retinopathies. Further studies are needed
to determine the safety and efficacy of somatostatin
analogs in neovascular ocular diseases.
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